Glomerular disease in 2016: New advances in the treatment of glomerular disease
Nature Reviews Nephrology 13, 65 (2017).
doi:10.1038/nrneph.2016.195
Authors: Rutger J. Maas & Jack F. Wetzels
Studies published in 2016 provide insights that bring us closer to achieving the goal of personalized therapy for primary glomerular diseases. Moreover, promising renal outcome data with new classes of glucose-lowering agents — SGLT2 inhibitors and GLP-1 agonists — offer new hope for patients with diabetic nephropathy.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Rutger J. Maas Jack F. Wetzels Tags: Year in Review Source Type: research